Aktiespot

Daewon Pharmaceutical Co., Ltd. (Daewonpharm) aktie

003220.KS

Stängt
₩12,400.00+1,160.00 (+10.32%)
Laddar diagram...

Daewonpharm

Öppning13,670.00
Högsta13,670.00
Lägsta11,610.00
Volym3.6M
P/EN/A
Börsvärde265.77B
52 veckors högsta14,700.00
52 veckors lägsta8,070.00
Genomsnittlig volym34.41k
Utdelning2.22%
Beta0.16
EPSN/A

Om Daewon Pharmaceutical Co., Ltd. (Daewonpharm) aktie

Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately 40 countries primarily in Asia, Central and South America, the Middle East, CIS, and Africa. The company was founded in 1958 and is headquartered in Seoul, South Korea.

Företagsinformation

Börs: KSE (KSC)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Special og generisk
Adress:
386 Cheonhodae-ro
Seoul, South Korea
Telefon: + 82 2 2204 7000

Analytikernas aktierekommendationer

Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.

Lägsta kursmål
13,000.00
4.8%
Genomsnittligt kursmål
14,666.67
18.3%
Median kursmål
15,000.00
21.0%
Högsta kursmål
16,000.00
29.0%

Andra tittar också på: